|
Match
|
Document |
Document Title |
|
|
5015631 |
Repairing agent for cells and tissues
A repairing agent for cells and tissues is disclosed, which agent comprises, as an active ingredient, a compound of the general formula: ##STR1## wherein Z represents lithium, potassium, sodium,...
|
|
|
5013661 |
Lipopolysaccharide-specific acyloxyacyl hydrolase
An acyloxyacyl hydrolase from the human promyelocyte cell line HL-60 has been found to specifically hydrolyze fatty acids from their ester linkages to hydroxy groups of 3-hydroxyfatty acids, the...
|
|
|
5013724 |
Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications
According to the process of the invention, a glycosaminoglycan is used in the form of a salt soluble in an organic medium and is subjected to the action of a given sulfation agent.
|
|
|
5013716 |
Unpleasant taste masking compositions and methods for preparing same
The present invention pertains to an unpleasant taste masking composition which comprises a flavoring agent having a bitter taste or unpleasant off-note and a sufficient amount of a non-bitter...
|
|
|
5013715 |
Pasty organopolysiloxane composition
The pasty organopolysiloxane composition is compounded from a methyl phenyl polysiloxane fluid and 5 to 50% by weight of a fatty acid ester of saccharose. The composition is highly transparent and...
|
|
|
5010059 |
Pharmaceutical products and lactosyl compounds
The compounds of the formula I exert a pronounced specific cytoprotective effect; they can be used for the treatment of acute and chronic inflammations and organ ischemias caused by narrowing of...
|
|
|
5006514 |
α,α-trehalose trimycolates and pharmaceutical compositions
An α,α-trehalose trimycolate represented by formula: ##STR1## (wherein R 1 through R 8 each represents a hydrogen atom or mycolic acid residue, and three of R 1 through R 8 are mycolic acid...
|
|
|
5001114 |
Alkyl mono and polyglycoside phosphate esters
New alkyl mono and polyglycoside phosphate esters and anionic derivatives thereof are described which compounds have the general formula RO(G) x Z y wherein G is a glycosyl moiety which is...
|
|
|
4999340 |
Rehydratable agarose gels
The present invention involves a method for separating biological molecules by subjection of said molecules to a separation system in a gel medium. The method most particularly involves the use of...
|
|
|
4996196 |
Novel desiccant and dehydration therewith
There are disclosed a novel desiccant containing anhydrous maltose and dehydration of hydrous matters, e.g. food, pharmaceutical and cosmetic, therewith. Such hydrous matters are dehydrated without...
|
|
|
4988679 |
Liquid sustained release composition
There is provided an orally ingestible liquid composition for suspending therein an orally administrable pharmaceutically active composition releasable over an extended period of time comprises...
|
|
|
4983584 |
Therapeutic and prophylactic agents for peptic ulcers
A therapeutic and prophylactic agent for peptic ulcers comprising as an effective ingredient a cyclohexane derivative represented by general formula (I): ##STR1## wherein A represents a group shown...
|
|
|
4983583 |
Granulated compositions of polysaccharides, process for their preparation and use
The present invention relates to granulated compositions of thickening and viscosity-raising polysaccharides having few anionic groups, wherein the polysaccharide particles are coated with...
|
|
|
4980462 |
Antiviral agents
A second-step virus binding receptor is found in nature on the surface of animal and plant cells. This receptor is thought to be needed for virus penetration into target cells. The second-step...
|
|
|
4980175 |
Liquid orally administrable compositions based on edible oils
Orally ingestible liquid compositions for suspending therein orally administrable pharmaceutically active compositions comprising triglycerides, propylene glycol ester, or monoacetylated glycerides...
|
|
|
4975281 |
Anti-ulcer composition
In accordance with the present invention a novel oral composition and method of using same for the treatment of ulcers and other gastrointestinal disorders is disclosed. The composition comprises...
|
|
|
4962093 |
Thiabendazole-containing antifungal composition
An antifungal agent comprising thiabendazole and a sucrose fatty acid ester, preferably, a sucrose ester of a fatty acid the residue of which has 8-18 carbon atoms.
|
|
|
4962092 |
Compositions for treating duodenal ulcers
Anti-anal leakage agents are used in combination with vitamin-fortified liquid fatty acid polyester compositions to provide pharmaceutical and food compositions for treating duodenal ulcers while...
|
|
|
4952687 |
Fatty acid esters of sugars and sugar alcohols
The oxidative stability of esters of unsaturated fatty acids and polyols having from 4-8 hydroxyl groups, preferably of sugars or sugar alcohols, more preferably of sucrose, is improved if the...
|
|
|
4950653 |
Solid iodophor composition
A solid iodophor composition contains a water-soluble iodophor, especially povidone iodine, and at least one of a urea and a sugar alcohol, especially mannitol, sorbitol or xylitol. The composition...
|
|
|
4950654 |
Hydrophilic theophylline powder formulation and its preparation
A hydrophilic theophylline powder formulation consisting of (a) from 5 to 15% by weight of theophylline, (b) from 15 to 30% by weight of lechithin, (c) from 45 to 80% by weight of sugar, ...
|
|
|
4946832 |
Cosmetic base composition with therapeutic properties
Cosmetic Base composition exhibiting therapeutic properties comprising an acyl fatty acid alpha-hydroxy carboxylic acid ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.
|
|
|
4946830 |
Agent and method for the prevention of metastases of malignant tumors
Agents and methods for the prevention of metastases of malignant tumors use the monosaccharides which are specific for organ cell lectins and/or glycoconjugates containing these monosaccharides,...
|
|
|
4945085 |
Use of sucralfate for controlling emesis and/or diarrhea
Sucralfate can be used to control and treat emesis and/or diarrhea in veterinary medicine.
|
|
|
4945084 |
Method and composition for topically treating anorectal or other dermal wounds
Hemorrhoidal compositions containing disaccharide polysulfate-aluminum compounds such as sucralfate, alone or in combination with other hemorrhoidal products, as an agent effective for alleviating...
|
|
|
4938961 |
Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
An organ preservation solution, particularly valuable in the preservation of mammalian hearts intended for transplantation, in aqueous solution, at least about 3% by weight of polypropylene glycol...
|
|
|
4937234 |
Minerals in bioavailable form
A soluble mineral in bioavailable form is formed from a mineral salt of a carboxylic acid derivative of a pentose or hexose such as zinc gluconate and an amino acid having the ability of stabilize...
|
|
|
4931554 |
Method of preparing a solid composition of lactulose, and composition so obtained
The invention relates to a method of preparing a solid composition of lactulose in a simple way. According to the invention lactulose syrup is mixed with Fiberform®, i.e. a fibre product based on...
|
|
|
4921838 |
Angiogenic and blood perfusion inducing properties of amphiphilic compounds
A method for enhancing angiogenesis and/or blood vascular perfusion in mammals by administering a pharmacologically effective amount of specific angiogenically active non-ionic, anionic, cationic...
|
|
|
4912093 |
Use of synthetic sulfated saccharides to enhance wound healing
The use of sulfated oligosaccharides, particularly mono- and disaccharides, and their salts to enhance healing of wounds is described. Preferred saccharides are those having three or more sulfate...
|
|
|
4895838 |
Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
A method for causing or increasing angiogenesis is described. The method involves administering to a subject, such as a human being in need of angiogenesis an angiogenically effective amount of an...
|
|
|
4886168 |
Device designed to preserve cosmetic substances that can be frozen
The present invention concerns a container containing dehydrated cosmetic substances placed in a case and ampoules of physiological serum or some other solution. These substances, stored at ambient...
|
|
|
4885282 |
Treatment of hyperhidrosis, ichthyosis and wrinkling
Skin suffering from emotional hyperhidrosis, ichthyosis with or without keratosis, and intrinsic or photoaging wrinkling is treated with mono- or discarboxylic acids containing 4 to 18 carbon...
|
|
|
4885281 |
Sucralfate suspension
The invention relates to formulations in the form of suspensions containing sucralfate, characterized in that they contain, based on the sucralfate, 1-5% by weight of xanthan gum and 1-12.5% by...
|
|
|
4880786 |
Additive solution for blood preservation and activation
There is disclosed an additive solution for blood preservation and activation, which comprises a phosphoenolpyruvic acid represented by the following formula (I): ##STR1## wherein R 1 represents a...
|
|
|
4879280 |
Dialysis solution for use in intraperitoneal dialysis
An aqueous solution for use in intraperitoneal dialysis made up of least one substance for regulation of the electrolyte balance in the body of the patient has a saccharide with at least one...
|
|
|
4873229 |
Galacto-oligosaccharide containing feed
A stock feed containing a specific amount of galacto-oligosaccharides, the stock feed being effective in the prevention of scours/loose passage of livestocks and thus in the increase of their weight.
|
|
|
4870059 |
Dehydration of hydrous matter with anhydrous maltose
There are disclosed a novel desiccant containing anhydrous maltose and dehydration of hydrous matters, e.g. food, pharmaceutical and cosmetic, therewith. Such hydrous matters are dehydrated without...
|
|
|
4851338 |
Method for diagnosing the presence of bacteria
A composition for therapeutic or diagnostic use in regard to pathogenic microorganisms, containing as an active constituent a structural element having the formula: ##STR1## wherein R 1 , R 2 , R 3...
|
|
|
4851392 |
Ingestible aggregate and delivery system prepared therefrom
The present invention relates to an ingestible aggregate comprising a pre-swelled substantially anhydrous hydrocolloid and a substrate. More particularly this invention relates to an aggregate...
|
|
|
4839347 |
Composition for treating dehydration
Composition for treating dehydration in swine is described according to the preferred embodiment of the teachings of the present invention for adminstration in the drinking water or feed of pigs....
|
|
|
4835142 |
Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
A powdery pharmaceutical composition for application to the mucosa of the oral or nasal cavity including: (a) a base selected from the group consisting of lower alkyl ethers of cellulose; (b) a...
|
|
|
4826962 |
Tetrachlororaffinose and its use in the preparation of sucralose
The novel chlorinated sugar O-α-D-6-chloro-6-deoxygalactopyranosyl-(1➝6)-α-D-4-chlo ro-4-deoxygalactopyranosyl-(1➝2)-β-D-1, 6-dichloro-1, 6-dideoxyfructofuranoside (TCR) can be used to...
|
|
|
4826825 |
Dehydration of hydrous product using anhydrous lactitol
A novel dehydration process using anhydrous lactitol as the desiccant is disclosed. Anhydrous lactitol is converted into the crystalline hydrate and acts as the desiccant when incorporated into a...
|
|
|
4816445 |
Crystalline alpha-maltose
A crystalline alpha-maltose with an alpha-maltose isomer content of 55% or higher is prepared by the process comprising preparing a high-concentration syrup, with a moisture content lower than 10...
|
|
|
4814347 |
Anthelmintic spiroketals and method of use
This invention pertains to a new method for killing and controlling worms (Helminths), new formulations for killing and controlling worms in animals, new chemical compounds, and a new synthesis of...
|
|
|
4812444 |
Dehydration of hydrous matter using anhydrous glycosylfructose
A novel dehydration method using anhydrous glycosylfructose as the desiccant is disclosed. Anhydrous glycosylfructose is converted to the crystalline hydrate and acts as the desiccant when...
|
|
|
4810827 |
Dehydration of hydrous matter using anhydrous aldohexose
A novel dehydration process using anhydrous aldohexose as the desiccant is disclosed. Anhydrous aldohexose is converted to crystalline hydrate and acts as the desiccant when it is incorporated into...
|
|
|
4782045 |
Promoting the proliferation of intestinal bifidobacteria
The present invention provides a method for promoting the proliferation of microorganisms of the genus Bifidibacterium comprising contacting said microorganisms with a growth promoting effective...
|
|
|
4761400 |
Laxative composition based on lactulose and its preparation process
Lactulose-based laxative composition which is in the form of a jelly with a viscosity at 20° C. measured on the Brookfield viscosimeter between 15,000 and 30,000 centipoises, a refractive index at...
|